Sermorelin Before and After — What the Results Actually Show

What the Controlled Evidence Shows

Since the photographs cannot answer the question, here is what can.

Sermorelin itself has been studied in adults, in two small randomized trials — six months in healthy older adults with cognitive endpoints, and twelve weeks in men with HIV-associated lipodystrophy, where lean mass rose and trunk fat fell while the absolute visceral-fat change did not reach significance. Neither produced anything resembling a month-by-month visible-results timeline, neither used a present-day compounded preparation, and neither photographed anybody. The record is narrow rather than absent — and narrow in a way that matters here, because nothing in it describes a visible change.

For wider context, the largest relevant body of evidence concerns growth hormone itself, given directly to healthy older adults. A 2007 systematic review in Annals of Internal Medicine pooled 31 articles describing 18 unique study populations — 220 treated participants, mean age 69 ³. Fat mass fell by roughly 2.1 kg and lean body mass rose by roughly 2.1 kg — real, measurable changes. But treated participants had significantly more adverse effects than placebo, including edema, joint pain, carpal tunnel syndrome and gynecomastia.

Two kilograms of recomposition, spread across a whole body, is not a dramatic photograph. It is a modest change that would be difficult to see reliably in an image — which is consistent with there being no images.

That figure is context, not a ceiling: growth hormone given directly and growth hormone released by stimulating your own pituitary differ in dose, exposure pattern and pharmacokinetics, so one does not set a numerical limit on the other.

So for sermorelin specifically, no controlled study has established the adult body-composition, sleep, energy, recovery or skin outcomes it is marketed for. Those are intended treatment goals, not established benefits, and no reliable onset timeline has been established.

Sermorelin is supplied today as a compounded preparation rather than an FDA-approved finished drug. Its historical approvals as GEREF® were for diagnostic use and pediatric growth hormone deficiency; the products were discontinued in 2008 and the approvals withdrawn effective June 18, 2009 ¹.

More detail: does sermorelin work?

Why Photographs Would Not Settle It Anyway

Suppose the photographs did exist. They still could not answer your question, and the reasons are worth knowing because they apply to every treatment marketed with images.

Photographs are extremely sensitive to how they are taken. Lighting direction, camera angle, distance and lens, posture, whether the abdomen is relaxed or braced, hydration, time of day, what was eaten, a recent workout, tan, and clothing all visibly alter the same person within a single afternoon. Paired images taken to demonstrate a result are usually not matched on any of these.

Published examples are selected ones. A clinic publishes its best outcomes; far fewer publish the patients who felt no different at month six. And a clinic rarely says how many people were treated in total — without that denominator, a set of impressive images tells you almost nothing about how likely the outcome is.

Nothing separates the drug from everything else that changed. People start sermorelin at a moment of intent — often alongside a new training program, better sleep, more protein, less alcohol, and the accountability of paying for a clinical program and returning for visits. Any of those produces visible change on its own. A photograph cannot attribute the difference to the injection.

There is no comparison group. This is the one that matters most. Without people going through the same program without the drug, there is no way to know what the drug contributed. That is what controlled trials are for, and it is exactly what is missing here.

Expectation is powerful, and these conditions maximize it. Treatment is unblinded, self-funded and framed positively. Reported improvement under those conditions is genuinely felt and genuinely unreliable as evidence about the drug.

About Those Month-by-Month Timelines

The timelines are remarkably consistent across sites, which can look like corroboration. It is worth being clear about what they are.

They describe what patients commonly report, in that order, and they are internally sensible — the things reported earliest are subjective (sleep, energy, mood), and the things reported latest are the ones that would take months to become visible. But every published version describes reported experience rather than measured endpoints, and no version cites controlled outcome data.

Notice also which order that is. Subjective improvements arrive first — and subjective reports are the ones most open to expectation, because there is nothing to check them against. Objective changes are placed at months three to six — far enough out that most people will have concluded the treatment is working long before anything measurable could confirm it.

Be especially cautious with any timeline paired with a specific percentage or dosing protocol. Historical GEREF evidence concerned specified products, formulations, routes, doses and populations, and does not establish dosing, quality or safety for present-day compounded preparations.

Will You Gain Weight on It?

This comes up often enough in searches to answer directly: it is possible for the scale to rise without any gain in fat.

Growth hormone can cause fluid retention, and retained fluid registers as weight. It can also inflate estimated lean mass on a body-composition scan, because lean mass is not skeletal muscle — it includes body water, organs, connective tissue and bone. An apparent "muscle gain" on a scan can partly be fluid.

Speak to a clinician promptly about new or worsening swelling, persistent joint pain, numbness or tingling in the hands, or new blood sugar problems.

See sermorelin side effects for interactions, contraindications and who should avoid it, and sermorelin and belly fat for the fat-loss question specifically.

What Would Actually Tell You Whether It Worked

If you are going to try something — this one or anything else — this is how to get the most informative answer available to you. Be clear about its limits first: even with a stable baseline and a pre-defined outcome, a single personal course cannot separate a treatment effect from normal fluctuation, expectation, regression to the mean or everything else changing at once. It can reasonably inform your own decision about continuing. It cannot establish that the treatment works.

Define the outcome before you start, in your own words. "I want to fall asleep faster and wake fewer times." "I want to lift the same weight for more reps." A goal you can state plainly is one you can check. "Feeling better" is not.

Take a real baseline. Measurements, a validated sleep or symptom questionnaire, a strength benchmark, relevant labs, body composition. Memory reconstructs the starting point to match the outcome you hoped for, reliably and without you noticing.

Standardize the conditions. If you photograph yourself, use the same room, light, time of day, distance, camera and posture — first thing in the morning, before eating. Most of the difference in a persuasive image pair is procedural.

Change one thing at a time — but never postpone the things that are already established. Nutrition, resistance training and treatment of an identified medical problem come first and should not be delayed to isolate an unapproved therapy. Where you do have a free choice about sequencing: if you begin training, dieting and injecting in the same week, you will not learn which one did it — and you may keep paying for the one that did nothing.

Set the review date and the stopping rule before you begin. Decide in advance what result at what date would justify continuing, and what would mean stopping. An open-ended course with no endpoint is not a plan, and the drug you cannot evaluate is the one you keep buying.

Before Any of This: Who Sermorelin Is Not For

A page about what results to expect is incomplete without who should not be starting at all — and compounded sermorelin has no FDA-approved label carrying a formal contraindication list. Clinicians prescribing on this axis treat the following as absolute: a prior allergic reaction to sermorelin, particularly anaphylaxis; pregnancy, planned near-term pregnancy or breastfeeding; active malignancy; significant hypothalamic-pituitary structural disease or an intracranial lesion; and acute critical illness or recent major surgery.

Treated as relative — individual assessment rather than a blanket rule: cancer in remission, including at five years, handled with the treating oncologist; diabetes, prediabetes or insulin resistance; uncontrolled thyroid disease; and significant liver or kidney disease.

Separately: sermorelin is prohibited by the World Anti-Doping Agency, a disqualifier for anyone competing under an anti-doping code regardless of prescription status.

Full list and the monitoring that goes with it: dosing and monitoring.

Red Flags

• Before-and-after photographs presented as evidence of a drug's effect — for any treatment, not only this one
• A results timeline with no cited outcome data
• "Well-documented" or "predictable" results with nothing linked
• Specific percentages, dosing protocols or success rates — no controlled adult outcome trials support them
• An injectable peptide shipped directly to you for self-treatment, with no prescriber and no documented clinical pathway — see peptide sourcing and quality

What You Can Do About It

Start from the symptom, not the product. The complaints that lead people to search this term — poor sleep, low energy, stubborn abdominal fat, slow recovery, aging skin — are worth taking seriously, and they have common causes that are treatable on established evidence. Untreated sleep apnea, thyroid dysfunction, insulin resistance, low testosterone, perimenopausal change, iron deficiency and medication side effects are common, treatable contributors — and finding one changes the result far more reliably than any peptide currently marketed.

Ask what the evidence is for that preparation, in your population, for your goal — not for growth hormone, not in patients with a diagnosed deficiency, not in children.

If fat loss is the goal, the approved medicines have the outcome data. See the GLP-1 hub and peptides for weight loss.

Get a baseline before starting anything. It is the difference between knowing whether something worked and believing it did.

Get Started with JumpstartMD

JumpstartMD was founded in 2007 by Stanford-trained physicians, and our weight-loss outcomes have been published in the peer-reviewed literature. You are seen face-to-face by licensed clinicians — in person at 14 California locations, or online across California.

Every visit includes clinical review and body-composition assessment under consistent conditions, so change is tracked against a measured baseline rather than against recollection.

Ready to talk?

Book FREE Consultation

Share your details and a JumpstartMD team member will reach out shortly. Or call 408.478.3496 for your free, no-obligation consultation.

Share your details and a JumpstartMD team member will reach out when we open.

Related Articles

• Does sermorelin work?
• Sermorelin — mechanism, evidence and current regulatory status
• Does sermorelin burn belly fat?
• Sermorelin side effects
• Sermorelin vs ipamorelin
• Sermorelin vs HGH
• Peptides for weight loss